Logo image of AVTR

AVANTOR INC (AVTR) Stock Fundamental Analysis

USA - NYSE:AVTR - US05352A1007 - Common Stock

12.79 USD
+0.39 (+3.15%)
Last: 9/18/2025, 12:13:09 PM
Fundamental Rating

4

Overall AVTR gets a fundamental rating of 4 out of 10. We evaluated AVTR against 55 industry peers in the Life Sciences Tools & Services industry. While AVTR is still in line with the averages on profitability rating, there are concerns on its financial health. AVTR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year AVTR was profitable.
AVTR had a positive operating cash flow in the past year.
In the past 5 years AVTR has always been profitable.
Each year in the past 5 years AVTR had a positive operating cash flow.
AVTR Yearly Net Income VS EBIT VS OCF VS FCFAVTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of AVTR (5.38%) is better than 78.18% of its industry peers.
With an excellent Return On Equity value of 10.94%, AVTR belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
AVTR has a Return On Invested Capital of 4.69%. This is in the better half of the industry: AVTR outperforms 69.09% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AVTR is significantly below the industry average of 15.96%.
Industry RankSector Rank
ROA 5.38%
ROE 10.94%
ROIC 4.69%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
AVTR Yearly ROA, ROE, ROICAVTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

AVTR's Profit Margin of 10.31% is fine compared to the rest of the industry. AVTR outperforms 76.36% of its industry peers.
In the last couple of years the Profit Margin of AVTR has grown nicely.
AVTR has a Operating Margin of 8.89%. This is in the better half of the industry: AVTR outperforms 65.45% of its industry peers.
In the last couple of years the Operating Margin of AVTR has grown nicely.
AVTR has a Gross Margin of 33.25%. This is in the lower half of the industry: AVTR underperforms 65.45% of its industry peers.
In the last couple of years the Gross Margin of AVTR has remained more or less at the same level.
Industry RankSector Rank
OM 8.89%
PM (TTM) 10.31%
GM 33.25%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
AVTR Yearly Profit, Operating, Gross MarginsAVTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

AVTR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AVTR has more shares outstanding than it did 1 year ago.
AVTR has more shares outstanding than it did 5 years ago.
AVTR has a better debt/assets ratio than last year.
AVTR Yearly Shares OutstandingAVTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AVTR Yearly Total Debt VS Total AssetsAVTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AVTR has an Altman-Z score of 1.71. This is a bad value and indicates that AVTR is not financially healthy and even has some risk of bankruptcy.
AVTR has a Altman-Z score (1.71) which is comparable to the rest of the industry.
The Debt to FCF ratio of AVTR is 7.63, which is on the high side as it means it would take AVTR, 7.63 years of fcf income to pay off all of its debts.
AVTR has a Debt to FCF ratio of 7.63. This is in the better half of the industry: AVTR outperforms 61.82% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that AVTR is not too dependend on debt financing.
The Debt to Equity ratio of AVTR (0.48) is worse than 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.63
Altman-Z 1.71
ROIC/WACC0.48
WACC9.7%
AVTR Yearly LT Debt VS Equity VS FCFAVTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AVTR has a Current Ratio of 0.98. This is a bad value and indicates that AVTR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, AVTR is not doing good in the industry: 89.09% of the companies in the same industry are doing better.
A Quick Ratio of 0.67 indicates that AVTR may have some problems paying its short term obligations.
With a Quick ratio value of 0.67, AVTR is not doing good in the industry: 92.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.67
AVTR Yearly Current Assets VS Current LiabilitesAVTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

AVTR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.09%.
Measured over the past years, AVTR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.82% on average per year.
AVTR shows a decrease in Revenue. In the last year, the revenue decreased by -2.34%.
AVTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.35% yearly.
EPS 1Y (TTM)3.09%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-4%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-1.14%

3.2 Future

AVTR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.29% yearly.
Based on estimates for the next years, AVTR will show a small growth in Revenue. The Revenue will grow by 3.40% on average per year.
EPS Next Y-3.4%
EPS Next 2Y2.24%
EPS Next 3Y5.56%
EPS Next 5Y10.29%
Revenue Next Year-2.86%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.2%
Revenue Next 5Y3.4%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVTR Yearly Revenue VS EstimatesAVTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
AVTR Yearly EPS VS EstimatesAVTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.79, the valuation of AVTR can be described as correct.
AVTR's Price/Earnings ratio is rather cheap when compared to the industry. AVTR is cheaper than 98.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of AVTR to the average of the S&P500 Index (27.20), we can say AVTR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 12.24, the valuation of AVTR can be described as correct.
Based on the Price/Forward Earnings ratio, AVTR is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
AVTR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.79
Fwd PE 12.24
AVTR Price Earnings VS Forward Price EarningsAVTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVTR is valued cheaper than 94.55% of the companies in the same industry.
89.09% of the companies in the same industry are more expensive than AVTR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.69
EV/EBITDA 12.27
AVTR Per share dataAVTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

The decent profitability rating of AVTR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.24%
EPS Next 3Y5.56%

More info and screens

0

5. Dividend

5.1 Amount

AVTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTOR INC

NYSE:AVTR (9/18/2025, 12:13:09 PM)

12.79

+0.39 (+3.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners99.28%
Inst Owner Change3.51%
Ins Owners0.3%
Ins Owner Change19.84%
Market Cap8.72B
Analysts72.41
Price Target14.29 (11.73%)
Short Float %4.56%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.72%
Min EPS beat(2)-5.09%
Max EPS beat(2)-2.36%
EPS beat(4)2
Avg EPS beat(4)-0.99%
Min EPS beat(4)-5.09%
Max EPS beat(4)2.94%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)7
Avg EPS beat(12)1.06%
EPS beat(16)10
Avg EPS beat(16)1.82%
Revenue beat(2)0
Avg Revenue beat(2)-2.51%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)-1.44%
Revenue beat(8)0
Avg Revenue beat(8)-2.07%
Revenue beat(12)0
Avg Revenue beat(12)-2.21%
Revenue beat(16)0
Avg Revenue beat(16)-2.27%
PT rev (1m)0%
PT rev (3m)-18.02%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)-14.89%
EPS NY rev (1m)-7.75%
EPS NY rev (3m)-7.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)-1.01%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 12.79
Fwd PE 12.24
P/S 1.31
P/FCF 15.69
P/OCF 12.79
P/B 1.39
P/tB N/A
EV/EBITDA 12.27
EPS(TTM)1
EY7.82%
EPS(NY)1.05
Fwd EY8.17%
FCF(TTM)0.82
FCFY6.38%
OCF(TTM)1
OCFY7.82%
SpS9.78
BVpS9.22
TBVpS-4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.38%
ROE 10.94%
ROCE 5.81%
ROIC 4.69%
ROICexc 4.91%
ROICexgc 74.82%
OM 8.89%
PM (TTM) 10.31%
GM 33.25%
FCFM 8.34%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
ROICexc(3y)6.76%
ROICexc(5y)6.74%
ROICexgc(3y)52.77%
ROICexgc(5y)49.06%
ROCE(3y)8.14%
ROCE(5y)8.11%
ROICexcg growth 3Y9.06%
ROICexcg growth 5Y15.03%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y1.59%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.63
Debt/EBITDA 2.99
Cap/Depr 31.03%
Cap/Sales 1.89%
Interest Coverage 3.4
Cash Conversion 68.32%
Profit Quality 80.87%
Current Ratio 0.98
Quick Ratio 0.67
Altman-Z 1.71
F-Score5
WACC9.7%
ROIC/WACC0.48
Cap/Depr(3y)35.33%
Cap/Depr(5y)30.17%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.71%
Profit Quality(3y)143.28%
Profit Quality(5y)453.06%
High Growth Momentum
Growth
EPS 1Y (TTM)3.09%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-4%
EPS Next Y-3.4%
EPS Next 2Y2.24%
EPS Next 3Y5.56%
EPS Next 5Y10.29%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-1.14%
Revenue Next Year-2.86%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.2%
Revenue Next 5Y3.4%
EBIT growth 1Y-17.23%
EBIT growth 3Y-9.65%
EBIT growth 5Y4.59%
EBIT Next Year3.61%
EBIT Next 3Y4.81%
EBIT Next 5Y8.1%
FCF growth 1Y-22.89%
FCF growth 3Y-6.35%
FCF growth 5Y18.01%
OCF growth 1Y-19.94%
OCF growth 3Y-4.11%
OCF growth 5Y18.89%